Shortening clinical trials contract turnaround by 20 percent—that is the goal of the new Clinical Research Support Office (CRSO). Processes for study staff and investigators will be simplified over time, and the institutional support functions are being brought under a single umbrella.
The new structure, launched on July 3, will streamline communications and functions across administrative units and offices, including clinical trials contracting, clinical research billing, and the clinical trials management system. The contracting triage function will continue to provide customer service for all the contracting offices at OHSU, including determining the appropriate contract office for execution.
Improved processes have already reduced the turnaround times for industry-sponsored clinical trials contracts. The average turnaround time in 2016 was 112 days. In the first quarter of 2017, it was 101 days. The goal for the next 12 months is a 90-day turnaround time.
A new director, currently being recruited, will be charged with ensuring the research community receives the support they need. This includes customer service, adherence to regulatory requirements, risk assessment and mitigation, and operational excellence.
The director and office will report to the vice president for research operations with joint reporting to the associate vice president for clinical and translational research and will work closely with key programs and units within OCTRI.